Short Interest in Tsumura & Co. (OTCMKTS:TSMRF) Increases By 58.5%

Tsumura & Co. (OTCMKTS:TSMRF) was the target of a significant increase in short interest in the month of August. As of August 31st, there was short interest totaling 381,950 shares, an increase of 58.5% from the August 15th total of 240,989 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Tsumura & Co. Stock Performance

TSMRF remained flat at $23.20 during midday trading on Thursday. The firm’s fifty day moving average is $23.20 and its two-hundred day moving average is $23.20. Tsumura & Co. has a 12-month low of $23.20 and a 12-month high of $25.75.

About Tsumura & Co.

Tsumura & Co is a Tokyo‐based pharmaceutical company specializing in the research, development and manufacture of Kampo medicines, which are traditional Japanese herbal remedies rooted in Chinese materia medica. The company’s core business revolves around the extraction, standardization and quality control of crude herbal ingredients, transforming them into prescription‐grade and over‐the‐counter products that are approved under Japan’s national health insurance system.

Leveraging a combination of modern analytical technology and traditional knowledge, Tsumura produces a broad portfolio of Kampo formulations for a range of therapeutic applications, including gastrointestinal health, circulatory support and immune regulation.